Clincosm LogoSign in Get a demo

Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

Sponsor
Technische Universität Dresden (Other)
Overall Status
Completed
CT.gov ID
NCT00180024
Collaborator
(none)
1
Location
44
Duration (Months)

Study Details

Study Description

Brief Summary

The hypothesis is tested that stimulation with angiotensin II after blockade of the AT1-receptor results in venodilation in human healthy subjects in vivo.

Condition or Disease Intervention/Treatment Phase
  • Drug: irbesartan (drug)
 N/A

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Educational/Counseling/Training
Study Start Date :
Jan 1, 2002
Study Completion Date :
Sep 1, 2005

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • healthy subjects
    Exclusion Criteria:
    • any relevant disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Institute of Clinical Pharmacology, Medical Faculty, University of Technology Dresden Germany 01307

    Sponsors and Collaborators

    • Technische Universität Dresden

    Investigators

    • Study Chair: Wilhelm Kirch, MD, Institute of Clinical Pharmacology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00180024
    Other Study ID Numbers:
    • IKPD 01-02
    First Posted:
    Sep 16, 2005
    Last Update Posted:
    Sep 16, 2005
    Last Verified:
    Sep 1, 2005
    Keywords provided by , ,
    AT1-receptor
    AT2-receptor
    human pharmacology
    Additional relevant MeSH terms:
    Irbesartan

    Study Results

    No Results Posted as of Sep 16, 2005